These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Search for evidence of a viral aetiology for inflammatory bowel disease. Yoshimura HH; Estes MK; Graham DY Gut; 1984 Apr; 25(4):347-55. PubMed ID: 6706214 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Ricciardi R; Ogilvie JW; Roberts PL; Marcello PW; Concannon TW; Baxter NN Dis Colon Rectum; 2009 Jan; 52(1):40-5. PubMed ID: 19273954 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
5. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons. Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621 [TBL] [Abstract][Full Text] [Related]
6. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968 [TBL] [Abstract][Full Text] [Related]
7. Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis. Brunner B; Scheurer U; Seibold F Dis Colon Rectum; 2007 Jan; 50(1):83-8. PubMed ID: 17096175 [TBL] [Abstract][Full Text] [Related]
8. Myoelectric effects of Clostridium difficile: motility-altering factors distinct from its cytotoxin and enterotoxin in rabbits. Justus PG; Martin JL; Goldberg DA; Taylor NS; Bartlett JG; Alexander RW; Mathias JR Gastroenterology; 1982 Oct; 83(4):836-43. PubMed ID: 7106514 [TBL] [Abstract][Full Text] [Related]
9. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Dorman SA; Liggoria E; Winn WC; Beeken WL Gastroenterology; 1982 Jun; 82(6):1348-51. PubMed ID: 7067956 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637 [TBL] [Abstract][Full Text] [Related]
11. Identification of a prodromal period in Crohn's disease but not ulcerative colitis. Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells. Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869 [TBL] [Abstract][Full Text] [Related]
13. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease. Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538 [TBL] [Abstract][Full Text] [Related]
14. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
17. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T; Voigt E; Gretzer B; Brasch F; May B Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639 [TBL] [Abstract][Full Text] [Related]
18. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047 [TBL] [Abstract][Full Text] [Related]
19. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]